CRSP logo

CRISPR Therapeutics AG (CRSP) EV/EBITDA

EV/EBITDA

-8.24
-0.26-3.26%

6 min ago


Summary


Performance

CRSP EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherCRSPvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

CRSP EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday-3.3%+3.2%+3.1%
1 m1 month-1.0%+1.0%+1.0%
3 m3 months+33.9%-5.5%-4.1%
6 m6 months+23.8%+1.8%-3.6%
ytdytd-11.8%+11.7%+11.4%
1 y1 year+73.1%-40.5%-41.9%
5 y5 years-129.7%+158.1%+15.0%

CRSP EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-9.9%-10.00+17.6%
3 m3-month-7.20-14.4%-13.09+37.0%
6 m6-month-7.20-14.4%-15.14+45.6%
1 y1-year-7.20-14.4%-31.32+73.7%
3 y3-year15.82-152.1%-36.33+77.3%
5 y5-year2149.62-100.4%-49.83+83.5%
alltimeall time2149.62-100.4%-732.31+98.9%

CRISPR Therapeutics AG EV/EBITDA History

DateValue
2025
-8.24(+11.8%)
2024
-7.37(-69.4%)
2023
-24.05(+371.6%)
2022
-5.10(-138.9%)
2021
13.12(-144.4%)
DateValue
2020
-29.57(-154.1%)
2019
54.62(-928.8%)
2018
-6.59(-43.1%)
2017
-11.58(-67.5%)
2016
-35.60

FAQ

  • What is CRISPR Therapeutics AG EV/EBITDA?
  • What is the all time high EV/EBITDA for CRISPR Therapeutics AG?
  • What is CRSP EV/EBITDA year-to-date change?
  • What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?

What is CRISPR Therapeutics AG EV/EBITDA?

The current EV/EBITDA of CRSP is -8.24

What is the all time high EV/EBITDA for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high EV/EBITDA is 2149.62

What is CRSP EV/EBITDA year-to-date change?

CRISPR Therapeutics AG EV/EBITDA has changed by -0.87 (-11.80%) since the beginning of the year

What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?

Over the past year, CRSP EV/EBITDA has changed by +22.35 (+73.06%)